GOLDMAN SACHS GROUP INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$6,864,000
+32.6%
6,945,000
+38.9%
0.00%
+100.0%
Q1 2021$5,175,000
-63.2%
5,000,000
-66.5%
0.00%
-75.0%
Q4 2020$14,062,000
+1.3%
14,944,000
-2.9%
0.00%0.0%
Q3 2020$13,883,000
-13.2%
15,394,000
-15.6%
0.00%
-20.0%
Q2 2020$16,003,000
-16.6%
18,247,000
-21.5%
0.01%
-28.6%
Q1 2020$19,193,000
+98.6%
23,247,000
+107.6%
0.01%
+250.0%
Q4 2019$9,663,000
+4.3%
11,197,000
+0.7%
0.00%
-33.3%
Q3 2019$9,265,000
+10.7%
11,116,000
+14.7%
0.00%
+50.0%
Q2 2019$8,367,0009,691,0000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders